Disruption of escherichia coli nissle 1917 K5 capsule biosynthesis, through loss of distinct kfi genes, modulates interaction with intestinal epithelial cells and impact on cell

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Nzakizwanayo, Jonathan ^a   Kumar, Sandeep ^a   Ogilvie, Lesley A ^a,c   Patel, Bhavik A ^a   Dedi, Cinzia ^a   Macfarlane, Wendy M ^a   Jones, Brian V ^a,b  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b QUEEN VICTORIA HOSPITAL   (United Kingdom)

^c ALACRIS THERANOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; CAPSULAR POLYSACCHARIDE K5; CYCLOOXYGENASE 2; ESCHERICHIA COLI PROTEIN; GLYCOSYLTRANSFERASE; KFIC PROTEIN, E COLI; PTGS2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; ASSAY; BACTERIAL CAPSULE; BACTERIAL GENE; BIOSYNTHESIS; CACO 2 CELL LINE; CELL ADHESION; CELL AGGREGATION; CELL INTERACTION; CELL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; GENE DISRUPTION; GENE IDENTIFICATION; GENE LOSS; HOST CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; MUTAGENESIS; MUTANT; PHENOTYPE; PROTEIN EXPRESSION; TRANSPOSON; BACTERIUM ADHERENCE; CACO-2 CELL LINE; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; INTESTINE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ESCHERICHIA COLI NISSLE 1917;

BACTERIAL ADHESION; BACTERIAL CAPSULES; CACO-2 CELLS; CYCLOOXYGENASE 2; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GLYCOSYLTRANSFERASES; HUMANS; INTESTINES; MUTAGENESIS, INSERTIONAL;

EID: 84925625457     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120430     Document Type: Article

References (59)

1. Foxx-Orenstein AE, Chey W. Manipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disorders. Am J Gastroenterol Suppl. 2012; 1: 41-46.
2. Shanahan F. Therapeutic implications of manipulating and mining the microbiota. J Physiol. 2009; 587: 4175-4179. doi: 10.1113/jphysiol.2009.174649 PMID: 19505978
3. O'Sullivan GC, Kelly P, O'Halloran S, Collins C, Collins JK, Dunne C, et al. Probiotics: an emerging therapy. Curr Pharm Des. 2005; 11: 3-10. PMID: 15641939
4. Ringel Y, Quigley EMM, Li HC. Using probiotics in gastrointestinal disorders. Am J Gastroenterol Suppl. 2012; 1: 34-40.
5. FAO/WHO. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food; Ontario, Canada. April 30, May 1, 2002.
6. Sonnenborn U, Schulze J. The non-pathogenic Escherichia coli strain Nissle 1917-features of a versatile probiotic. Microb Ecol Health Dis. 2009; 21: 122-158.
7. Nissle A. Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Med Klin. 1918; 2: 29-33.
8. Schultz M. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm Bowel Dis. 2008; 14: 1012-1018. doi: 10.1002/ibd.20377 PMID: 18240278
9. Kruis W, Schütz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 1997; 11: 853-858. PMID: 9354192
10. Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53:1617-1623. PMID: 15479682
11. Matthes H, Krummenerl T, Giensch M, Wolff C, Schulze J. Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle (EcN). BMC Complement Altern Med. 2010; 10:13. doi: 10.1186/1472-6882-10-13 PMID: 20398311
12. Cukrowska B, LodInová-ZádnIková R, Enders C, Sonnenborn U, Schulze J, Tlaskalová-Hogenová H. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol. 2002; 55: 204-209. PMID: 11896937
13. Henker J, Laass M, Blokhin BM, Bolbot YK, Maydannik VG, Elze M, et al. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr. 2007; 166: 311-318. PMID: 17287932
14. Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherentinvasive E. coli strains isolated from patients with Crohn's disease. Aliment Pharmacol Ther. 2003; 18: 45-56. PMID: 14531740
15. Lodinová-Zádniková R, Sonnenborn U. Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate 1997; 71: 224-232. PMID: 9129791
16. Ukena SN, Westendorf AM, Hansen W, Rohde M, Geffers R, Coldewey S, et al. The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1. BMC Med Genet. 2005; 6: 43. doi: 10.1186/1471-2350-6-43 PMID: 16351713
17. Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun. 2006; 74: 4075-4082. PMID: 16790781
18. Hafez M, Hayes K, Goldrick M, Warhurst G, Grencis R, Roberts IS. The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction. Infect Immun. 2009; 77: 2995-3003. doi: 10.1128/IAI.00040-09 PMID: 19380467
19. Hafez M, Hayes K, Goldrick M, Grencis RK, Roberts IS. The K5 capsule of Escherichia coli strain Nissle 1917 is important in stimulating expression of Toll-like receptor 5, CD14, MyD88, and TRIF together with the induction of interleukin-8 expression via the mitogen-activated protein kinase pathway in epithelial cells. Infect Immun. 2010; 78: 2153-2162. doi: 10.1128/IAI.01406-09 PMID: 20145095
20. Schlee M, Wehkamp J, Altenhoefer A, Oelschlaeger TA, Stange EF, Fellermann K. Induction of Human β-Defensin 2 by the Probiotic Escherichia coli Nissle 1917 Is Mediated through Flagellin. Infect Immun. 2007; 75: 2399-2407. PMID: 17283097
21. Sturm A, Rilling K, Baumgart DC, Gargas K, Abou-Ghazalé T, Raupach B, et al. Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling. Infect Immun. 2005; 73: 1452-1465. PMID: 15731043
22. Guzy C, Paclik D, Schirbel A, Sonnenborn U, Wiedenmann B, Sturm A. The probiotic Escherichia coli strain Nissle 1917 induces ãä T cell apoptosis via caspase- and FasL-dependent pathways. Int Immunol. 2008; 20: 829-840. doi: 10.1093/intimm/dxn041 PMID: 18448456
23. Otte JM, Mahjurian-Namari R, Brand S, Werner I, Schmidt WE, Schmitz F. Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr Cancer 2009; 61: 103-113. doi: 10.1080/01635580802372625 PMID: 19116880
24. Wang D, Dubois RN. The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 2010; 29: 781-788. doi: 10.1038/onc.2009.421 PMID: 19946329
25. Wallace JL. Prostaglandin biology in inflammatory bowel disease. Gastroenterol Clin North Am. 2001; 30: 971-980. PMID: 11764538
26. Ritland SR, Gendler SJ. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. Carcinogenesis 1999; 20: 51-58. PMID: 9934849
27. Rhodes JM, Campbell BJ. Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med. 2002; 8: 10-16. PMID: 11796261
28. Cress BF, Linhardt RJ, Koffas MA. Draft Genome Sequence of Escherichia coli Strain Nissle 1917 (Serovar O6:K5:H1). Genome Announc. 2013; 1: e00047-13. doi: 10.1128/genomeA.00047-13
29. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, et al. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol. 2004; 186: 5432-5441. PMID: 15292145
30. Grozdanov L, Zähringer U, Blum-Oehler G, Brade L, Henne A, Knirel YA, et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol. 2002; 184: 5912-5925. PMID: 12374825
31. Vejborg RM, Friis C, Hancock V, Schembri MA, Klemm P. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics 2010; 283: 469-484. doi: 10.1007/s00438-010-0532-9 PMID: 20354866
32. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241. PMID: 15260992
33. Lundin A, Bok CM, Aronsson L, Björkholm B, Gustafsson JA, Pott S, et al. Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine. Cell Microbiol. 2008; 10: 1093-1103. PMID: 18088401
34. Pålsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004; 113: 153-162. PMID: 15379975
35. Lasaro MA, Salinger N, Zhang J, Wang Y, Zhong Z, Goulian M, et al. F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917. Appl Environ Microbiol. 2009; 75: 246-251. doi: 10.1128/AEM.01144-08 PMID: 18997018
36. Griffiths G, Cook NJ, Gottfridson E, Lind T, Lidholt K, Roberts IS. Characterization of the glycosyltransferase enzyme from the Escherichia coli K5 capsule gene cluster and identification and characterization of the glucuronyl active site. J Biol Chem. 1998; 273: 11752-11757. PMID: 9565598
37. Pratt LA, Kolter R. Genetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I pili. Mol Microbiol. 1998; 30: 285-293. PMID: 9791174
38. Chilcott GS, Hughes KT. Coupling of flagellar gene expression to flagellar assembly in Salmonella enterica serovar typhimurium and Escherichia coli. Microbiol Mol Biol Rev. 2000; 64: 694-708. PMID: 11104815
39. Troge A, Scheppach W, Schroeder BO, Rund SA, Heuner K, Wehkamp J, et al. More than a marine propeller - the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus. Int J Med Microbiol. 2012; 302: 304-314. doi: 10.1016/j.ijmm.2012.09.004 PMID: 23131416
40. Klemm P, Schembri MA. Bacterial adhesins: function and structure. Int J Med Microbiol. 2000; 290: 27-35. PMID: 11043979
41. Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem. 2006; 75: 39-68. PMID: 16756484
42. Petit C, Rigg GP, Pazzani C, Smith A, Sieberth V, Stevens M, et al. Region 2 of the Escherichia coli K5 capsule gene cluster encoding proteins for the biosynthesis of the K5 polysaccharide. Mol Microbiol. 1995; 17: 611-620. PMID: 8801416
43. Bliss JM, Silver RP. Coating the surface: a model for expression of capsular polysialic acid in Escherichia coli K1. Mol Microbiol. 1996; 21: 221-231. PMID: 8858578
44. Hodson N, Griffiths G, Cook N, Pourhossein M, Gottfridson E, Lind T, et al. Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha-UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC. J Biol Chem. 2000; 275: 27311-27315. PMID: 10859322
45. Corbett D, Roberts IS. Capsular polysaccharides in Escherichia coli. Adv Appl Microbiol. 2008; 65: 1-26. doi: 10.1016/S0065-2164(08)00601-1 PMID: 19026860
46. Whitfield C, Roberts IS. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol. 1999; 31: 1307-1319. PMID: 10200953
47. Rigg GP, Barrett B, Roberts IS. The localization of KpsC, S and T, and KfiA, C and D proteins involved in the biosynthesis of the Escherichia coli K5 capsular polysaccharide: evidence for a membranebound complex. Microbiology 1998; 144: 2905-2914. PMID: 9802032
48. Pelkonen S. Capsular sialyl chains of Escherichia coli K1 mutants resistant to K1 phage. Curr Microbiol. 1990; 21: 23-28.
49. Pelkonen S, Aalto J, Finne J. Differential activities of bacteriophage depolymerase on bacterial polysaccharide: binding is essential but degradation is inhibitory in phage infection of K1-defective Escherichia coli. J Bacteriol. 1992; 174: 7757-7761. PMID: 1447142
50. Schembri MA, Dalsgaard D, Klemm P. Capsule shields the function of short bacterial adhesins. J Bacteriol. 2004; 186: 1249-1257. PMID: 14973035
51. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, Schembri MA. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun. 2007; 75: 3233-3244. PMID: 17420234
52. Hanna A, Berg M, Stout V, Razatos A. Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli. Appl Environ Microbiol. 2003; 69:4474-4481. PMID: 12902231
53. Larsen RA, Wilson MM, Guss AM, Metcalf WW. Genetic analysis of pigment biosynthesis in Xanthobacter autotrophicus Py2 using a new, highly efficient transposon mutagenesis system that is functional in a wide variety of bacteria. Arch Microbiol. 2002; 178: 193-201. PMID: 12189420
54. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998; 30: 295-304. PMID: 9791175
55. Manoil C. Tagging exported proteins using Escherichia coli alkaline phosphatase gene fusions. Methods Enzymol. 2000; 326: 35-47. PMID: 11036633
56. Bloor AE, Cranenburgh RM. An efficient method of selectable marker gene excision by Xer recombination for gene replacement in bacterial chromosomes. Appl Environ Microbiol. 2006; 72: 2520-2525. PMID: 16597952
57. Gupta DS, Jann B, Schmidt G, Golecki JR, Ørskov I, Ørskov F, et al. Coliphage K5, specific for E. coli exhibiting the capsular K5 antigen. FEMS Microbiol Lett. 1982; 14: 75-78.
58. Willis LM, Whitfield C. KpsC and KpsS are retaining 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) transferases involved in synthesis of bacterial capsules. Proc Natl Acad Sci U S A. 2013; 110: 20753-20758. doi: 10.1073/pnas.1312637110 PMID: 24302764
59. Jones BV, Young R, Mahenthiralingam E, Stickler DJ. Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection. Infect Immun. 2004; 72: 3941-3950.